BioSpace News Archive

A recent study in Plastic and Reconstructive Surgery, the Journal of the American Society of Plastic Surgeons, reports that AmnioBand® Membrane, an aseptically processed, dehydrated human amnion/chorion allograft (dHACA) developed by MTF Biologics, offers greater wound closure for those with chronic venous leg ulcers than standard of care alone.

National Resilience, Inc. (Resilience) and AstraZeneca PLC announced today that the companies will establish a long-term biomanufacturing relationship in support of AstraZeneca’s portfolio.

The American Association of Medical Assistants® announced the installation of Deborah Novak, CMA, as the organization’s newly elected 2022-2023 president at the 66th AAMA Annual Conference.

At Vetter, a globally leading contract development and manufacturing organization (CDMO), numerous ideas for improving processes and further development of the overall company have been coming directly from colleagues in various departments

Eargo, Inc., a medical device company on a mission to improve the quality of life for people with hearing loss, announced the closing and final results of its rights offering, which expired at 5:00 p.m. New York City time, on November 17, 2022.

Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies, announced it has entered into a definitive agreement to be acquired by AstraZeneca.

True You Weight Loss has enrolled the first patient in the nation in a groundbreaking study to investigate the effects of gastric fundus ablation combined with Endoscopic Sleeve Gastroplasty (ESG) for the management of obesity.

Turnstone Biologics Corp today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to evaluate the generation of tumor-reactive T-cells, which form the basis of Turnstone’s tumor-infiltrating lymphocyte platform.

Today, Synexis ® , LLC announced the appointment of Dennis Doyle as the new chief executive officer (CEO) and James “Jimmy” Robert as its first chief commercial officer (CCO).

Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases, today announced the publication of “Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells,” in Communications Biology.